Kelly T A, McNeil D W, Rose J M, David E, Shih C K, Grob P M
Research and Development Center, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut 06877, USA.
J Med Chem. 1997 Jul 18;40(15):2430-3. doi: 10.1021/jm960837y.
Modification of the non-nucleoside inhibitor of HIV-1 reverse transcriptase nevirapine (Viramune) by incorporation of a 2-indolyl substituent confers activity against several mutant forms of the enzyme.